Tag Archives: AmideBio

AmideBio Closes $575K Round

May 11, 2011 – 10:38 am

AmideBio announced that it has closed a $575,000 preferred equity financing round. The source of the funds was not disclosed. AmideBio uses proprietary “Cap-Clip” technology, exclusively licensed from the University of Colorado, to produce and commercialize technically challenging peptides. This technology has the potential to both lower costs and improve purity in peptide [...]

By admin | Posted in Life Science | Also tagged | Comments (0)

Sharklet Wins Biowest Venture Showcase

October 1, 2010 – 8:44 am

The first day of CBSA’s annual BioWest Conference brought the always-popular venture showcase in which the four finalists, selected from 21 entrants, presented their technologies to a panel of investors. Brief descriptions of the four finalists follow.
AmideBio, presented by CEO Misha Plam, has a process to manufacture peptides more efficiently and economically. The proprietary [...]

By admin | Posted in Life Science | Also tagged , , | Comments (0)

AmideBio Brings in Seed Funding

January 28, 2010 – 3:16 pm

AmideBio, LLC announced that it has closed a round of seed funding. The source and the amount of funding were not disclosed by the company. The proceeds of the round will be used to complete initial product optimization using its recombinant hydrid manufacturing technology. AmideBio has an exclusive license, announced two week ago, [...]

By admin | Posted in Life Science | Also tagged | Comments (0)

AmideBio Licenses Protein Manufacture Method from CU

January 11, 2010 – 6:25 pm

AmideBio LLC has executed an exclusive license with the University of Colorado to develop, manufacture, and commercialize peptides based on the work of CU Boulder Associate Professor Michael Stowell. The technology licensed encompasses a method to manufacture recombinant proteins and peptides that is believed to be both economically viable and sustainable. Recombinant proteins [...]

By admin | Posted in Life Science | Also tagged , | Comments (2)